Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritis

Fig. 1

Interaction between treatment and cardiovascular disease risk factors on aortic stiffness index (two-way ANCOVA). Data are presented as adjusted estimated means of follow-up AoSI (bullets and squares) and their 95% confidence intervals (vertical error bars). csDMARDs, conventional synthetic disease-modifying anti-rheumatic drugs; TNFi, tumour necrosis factor inhibitors

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us